Skip to main content
HSCT
OTC Technology

HOOPS SCOUTING USA Reports Worsening Losses, Going Concern Warning, and Ineffective Controls

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$0.39
Mkt Cap
0
52W Low
$0.02
52W High
$0.53
Market data snapshot near publication time

summarizeSummary

HOOPS SCOUTING USA reported worsening financial results, including a going concern warning and ineffective disclosure controls, despite generating its first revenue.


check_boxKey Events

  • Going Concern Warning Issued

    The company disclosed substantial doubt about its ability to continue as a going concern due to significant operating losses, a working capital deficit of $230,973, and an accumulated deficit of $382,023 as of March 31, 2026.

  • Disclosure Controls Deemed Ineffective

    Management concluded that the company's disclosure controls and procedures were not effective as of March 31, 2026, indicating potential weaknesses in financial reporting oversight.

  • Worsening Financial Performance

    Net loss for the nine months ended March 31, 2026, increased to $70,186 from $18,796 in the prior year period. The working capital deficit widened to $230,973 from $160,787 at June 30, 2025.

  • Reliance on Related Party Financing

    The company continues to depend on its President for funding, with $40,411 in proceeds from a related party during the nine months ended March 31, 2026, and an additional $10,000 received after the quarter end. Total owed to the President is $275,355.


auto_awesomeAnalysis

HOOPS SCOUTING USA's latest 10-Q reveals a significant deterioration in its financial health, marked by increasing net losses and a widening working capital deficit. The company explicitly states substantial doubt about its ability to continue as a going concern, relying heavily on its President for financing. Furthermore, management concluded that its disclosure controls and procedures were not effective, raising serious concerns about the reliability of its financial reporting.

At the time of this filing, HSCT was trading at $0.39 on OTC in the Technology sector. The 52-week trading range was $0.02 to $0.53. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HSCT - Latest Insights

HSCT
May 13, 2026, 8:12 AM EDT
Filing Type: 10-Q
Importance Score:
8